Author

Javier Poyatos‐García

Hospital Universitari i Politècnic La FeORCID 0000-0003-3117-4743Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Andrea López‐MartíneziD· 2 shared Patricia Soblechero‐MartíniD· 2 shared Virginia Arechavala‐GomezaiD· 2 shared Aina AntoniD· 1 shared Alessandro LiquoriiD· 1 shared E. Albiasu-Arteta· 1 shared Elisa González-Romero· 1 shared Estibaliz Ruiz-del-YerroiD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Andrea López‐MartínezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologySkeletal MusclePeer-reviewedOct 1, 2024

Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model

Javier Poyatos‐García, Patricia Soblechero‐Martín, Alessandro Liquori…·Juan Jesus Vilchez

The paper restores dystrophin expression in DMD cells by replicating a specific exon deletion and creates a new cell model to study the mutation's effects.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky

NeuroscienceScientific ReportsPeer-reviewedSep 14, 2021

Duchenne Muscular Dystrophy Cell Culture Models Created By CRISPR/Cas9 Gene Editing And Their Application To Drug Screening

Patricia Soblechero‐Martín, E. Albiasu-Arteta, Aina Anton…·Virginia Arechavala‐Gomeza

The paper describes CRISPR/Cas9-generated Duchenne muscular dystrophy cell models for drug screening, showing successful exon deletion and utrophin upregulation.

20 citations

humanexperimental assay

𝕏 PostBluesky